Elevated B-type natriuretic peptide level: Use with caution in patients with multiple co-morbidities and presenting with dyspnea

Indian Heart Journal

Volumn 59, Issue 1, 2007, Pages 64-68

  Jeevanantham, Vinodh ^a,b   Shrivastava, Rakesh ^a   Nannapaneni, Srikant ^a   Khan, Aameera ^a   Sengodan, Mohan ^a   Nautiyal, Amit ^a   Navaneethan, Sankar ^a   Hsi, David ^a  

^a UNITY HEALTH SYSTEM   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

BNP; Co morbidities; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPNEA; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PLEURA EFFUSION; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; REGRESSION ANALYSIS; SEX DIFFERENCE; UNIVARIATE ANALYSIS;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS;

EID: 34047186489     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Nagagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995;96:1280-87.
2. Maeda K, Takayoshi T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
3. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-67
4. McCullough PA, Hollander JE, Nowak RM, et al. Uncovering heart failure in patients with a history of pulmonary disease: a rationale for the early use of B-type natriuretic peptide in emergency department. Acad Emerg Med 2003;10:275-77.
5. Morrison KL, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-09.
6. Sirithunyanont C, Leowattana W, Sukumalchantra Y, et al. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other causes. J Med Assoc Thai 2003;86:87-95.
7. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-85.
8. Doust JA, Glasziou PP, Pietrzak E, et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch intern Med 2004;164:1978-84.
9. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002;39:131-38.
10. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-63.
11. Schnabel R, Lubos E, Rupprecht HJ, et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study. J Am Coll Cardiol 2006;47:552-58.
12. Mueller C, Laule-Kilian K, Scholer A, et al. Use of B-type natriuretic peptide for the management of women with dyspnea. Am J Cardiol 2004;94:1510-14.
13. Mueller C, Laule-Kilian K, Frana B, et al. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. Am Heart J 2006;151:471-77.
14. Knudsen CW, Omland T, Clopton P, et al. Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med 2004;116:363-68.
15. Dokainish H, Zoghbi WA, Lakkis NM, et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 2004;93:1130-35.
16. Williams SG, Ng LL, O'Brien RJ, et al. Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. Eur J Heart Fail 2004;6:891-900.
17. Williams SG, Ng LL, O'Brien RJ, et al. Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and LVEF for severity of chronic heart failure. Am J Cardiol 2004;93:1560-61.
18. Maisel AS, Clopton P, Krishnaswamy P, et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly multinational study. Am Heat J 2004;147:1078-84.
19. Knudsen CW, Riis JS, Finsen AV, et al. Diagnostic value of a rapid test for B-type natriuretic peptide in patients presenting with acute dyspnea: effect of age and gender. Eur J Heart Fail 2004;6:55-62.
20. Redfield MM, Rodheffer RF, Mahoney DW, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40: 976-82.
21. Wang TJ, Larson M, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254-58.
22. McLean AS, Huang SJ, Nalos M, et al. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003;31:2611-18.
23. Emdin M, Passino C, Del Ry S, et al. Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. Clin Chem Lab Med 2003;41:686-92.
24. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: analysis from the Breathing Not Properly multinational study. Am J Kidney Dis 2003;41:571-79.
25. Tsutamoto T, Wada A, Sakai H, et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006;47:582-86.
26. McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev 2003;8:355-58.
27. McCord J, Mundy BJ, Hudson MP, et al. Breathing Not Properly Multinational Study Investigators. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004;164:2247-52.
28. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004;43:1590-95.
29. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594-600.
30. Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005;112:2163-68.
31. Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 2006;47:85-90.
32. Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 2005; 294:1944-56.
33. Leuchte HH, Holzapfel M, Baumgartner RA, Neurohr C, Vogeser M, Behr J. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension. Chest 2005;128:2368-74.